Klaassen1 project protocol

Cadmium toxicity in the testes, liver, and trigeminal ganglia in males of 8 inbred strains of mice   (2001)

Klaassen CD
With: Habeebu SS, Liu Y, Park JD

See also: Klaassen1 animal documentation


Klaassen1_Protocol

Project protocol — Contents
Workflow and sampling
Equipment
Reagents, supplies, and solutions
Procedures

Definitions
Data
References



Workflow and sampling

Workflow

Day
Procedure accomplished
Equipment
Data Collected
1
Mice are injected with cadmium via tail vein
-
-
2_a
Mice are anesthetize with pentobarbital i.p.
-
-
2_b
Mice are perfused with saline and fixative
whole body perfusion setup
-
2_c
Liver, trigeminal ganglia, and testes are harvested
dissecting kit
-
2_d
Cd content is measured in the liver, trigeminal ganglia, and testes, before complete overnight fixation for 24 h
gamma scintillation spectrometer
(radio-active Cd incorporation) not submitted
3
Fully fixed liver, trigeminal ganglia, and testes are processed for histopathology
microtome, histology setup
-
4+
Histopathology samples are evaluated microscopically
light microscope
resistance, susceptibility to Cd toxicity, liver necrosis (score 0-4)

Equipment

Dissecting kit
Packard gamma scintillation spectrometer
• Balance scale
Microtome for tissue sectioning
Light microscope

Reagents, supplies, solutions  

Cadmium chloride (CdCl2) reagent grade, Fisher Scientific Co. (Fair Lawn, NJ)
109CdCl2 (5.12 µCi/mg), New England Nuclear Research Products (Boston, MA)
Needles and syringes
Perfusion setup
Physiological saline (0.9% NaCl)
Pentobarbital (60 mg/kg)
0.4% paraformaldehyde,10% neutral formalin
Hematoxylin and eosin (H&E)

Procedures

Histopathology of cadmium toxicity
a. Treated male mice (5-4 per strain per study group) are injected with 15 µmol CdCl2/kg (20 µCi 109Cd/kg) i.v., dissolved in physiological saline (0.9% NaCl) in a volume of 10 mL/kg BW bolus, via the tail dorsal vein, while the control group is given saline vehicle.
b.
After 24 hrs following CD administration, the mice are deeply anesthetized with 60 mg/kg BW dose of pentobarbital.
c.
Under adequate anesthesia, the thoracic cavity is opened for total body perfusion via the heart, initially with normal saline to flush the blood, and then with freshly made 0.4% paraformaldehyde for pre-fixation.
d. The perfusion pre-fixed brains, trigeminal ganglias, liver, and testes are dissected, weighed, and Cd content determined using gamma scintillation spectrometry.
e. Following Cd content ditermination, the organs are placed in fresh 0.4% paraformaldehyde or 10% neutral formalin for 24 h.
f. Fully fixed liver, ganglia, and testes are then processed via standard histopathological techniques, sectioned at 5 µm thickness, and stained with H&E.
g.
Three sections from the each entire trigeminal ganglion, liver, and testes (9 sections from each mouse) are microscopically evaluated and scored for cadmium toxicity (see Figures 1-4 below).
h.
Liver sections are evaluated for necrosis, apoptosis, and other lesions; hepatocytes (1500–2500 per mouse) in 12–20 randomly selected fields are counted under 400X magnification, aided by a grid of 100 squares (see Figures 1-2 below).
i.
Apoptotic index (AI) and mitotic index (MI) are determined by dividing the total number of hepatocytes showing apoptosis (apoptotic cells and bodies) or mitosis by the total number of cells in the fields examined. Clusters of two or three apoptotic bodies are regarded as single apoptotic events (Habeebu et al, 1998).
j .
Typing of apoptotic cells and bodies (intracellular or extracellular, chromatin-containing or non-chromatin-containing) is done at 1000X magnification or 100X objective (with oil immersion).
k.
Necrosis is analyzed semiquantitatively with five scores for severity: 0= none; 1= necrosis of 1–5% of hepatocytes; 2=necrosis of 6–25% of hepatocytes; 3=necrosis of 26–50% of hepatocytes; and 4=necrosis of >50% of hepatocytes.


Figure 1.
A schematic example of a partially necrotic liver-partly overlayed with a scoring grid.


Figure 2. Photomicrograph illustrations of (A) normal untreated liver, and (B) cadmium-treated liver showing marked hepatic necrosis.


Figure 3. Photomicrograph illustrations of (A) normal untreated ganglion cells, and (B-C) cadmium-treated ganglion cells showing neurotoxicity (i.e. red blood cells surrounding ganglion cells in panel B, and pale nuclear staining or "ghost cells" in panel C).


Figure 4. Photomicrograph illustrations of (A) normal testis, and (B) testis showing cellular degeneration (round cells with pyknotic or fragmenting nuclei).

Data collected by investigator

Cadmium-induced toxicity to the liver, testis and trigeminal ganglia.



References

    Choudhuri S, Liu WL, Berman NE, Klaassen CD. Cadmium accumulation and metallothionein expression in brain of mice at different stages of development. Toxicol Lett. 1996 Mar;84(3):127-33. PubMed 8600611

    Habeebu SS, Liu J, Klaassen CD. Cadmium-induced apoptosis in mouse liver. Toxicol Appl Pharmacol. 1998 Apr;149(2):203-9. PubMed 9571989

    Harstad EB, Klaassen CD. Analysis of strain difference in sensitivity to cadmium-induced hepatotoxicity in Fischer 344 and Sprague-Dawley rats. Toxicol Sci. 2002 Jun;67(2):329-40. PubMed 12011493

    Klaassen CD, Liu J, Diwan BA. Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol. 2009 Aug 1;238(3):215-20. Epub 2009 Apr 9. PubMed 19362100   FullText